. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. J Neuropathol Exp Neurol. 2015 Jul;74(7):672-87. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(27)
201 ± 18
pg/mL
xMAP;
AlzBio3;
Fujirebio
McKhann et al., 2011
Aβ42
(CSF)
CTRL-
CNC
(23)
311 ± 29
pg/mL
xMAP;
AlzBio3;
Fujirebio
Aβ42
(CSF)
PD
(24)
348 ± 22
pg/mL
xMAP;
AlzBio3;
Fujirebio
tau-p181
(CSF)
AD
(27)
69 ± 7
pg/mL
xMAP;
AlzBio3;
Fujirebio
McKhann et al., 2011
tau-p181
(CSF)
CTRL-
CNC
(23)
39 ± 4
pg/mL
xMAP;
AlzBio3;
Fujirebio
tau-p181
(CSF)
PD
(24)
27 ± 2
pg/mL
xMAP;
AlzBio3;
Fujirebio
tau-total
(CSF)
AD
(27)
101 ± 7
pg/mL
xMAP;
AlzBio3;
Fujirebio
McKhann et al., 2011
tau-total
(CSF)
CTRL-
CNC
(23)
57 ± 4
pg/mL
xMAP;
AlzBio3;
Fujirebio
tau-total
(CSF)
PD
(24)
39 ± 4
pg/mL
xMAP;
AlzBio3;
Fujirebio

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.